C677T mutation in methylenetetrahydrofolate reductase gene and neural tube defects: Should Japanese women undergo gene screening before pregnancy?

Congenital Anomalies

Volumn 54, Issue 1, 2014, Pages 30-34

  Kondo, Atsuo ^a   Fukuda, Hiromi ^b   Matsuo, Takuya ^c   Shinozaki, Keiko ^d   Okai, Ikuyo ^a  

^a Tsushima Rehabilitation Hospital   (Japan)

^b AICHI UNIVERSITY OF EDUCATION   (Japan)

^c KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

Gene screening; Methylenetetrahydrofolate reductase; Neural tube defects; Spina bifida; Spina bifida mothers

Indexed keywords

GENE SCREENING; METHYLENETETRAHYDROFOLATE REDUCTASE; NEURAL TUBE DEFECTS; SPINA BIFIDA; SPINA BIFIDA MOTHERS;

ADULT; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC TESTING; HUMANS; JAPAN; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; NETHERLANDS; NEURAL TUBE DEFECTS; POINT MUTATION; POLYMORPHISM, GENETIC; PREGNANCY; SPINAL DYSRAPHISM;

EID: 84894496655     PISSN: 09143505     EISSN: 17414520     Source Type: Journal    
DOI: 10.1111/cga.12026     Document Type: Article

References (30)

1. Banhidy F, Puho EH, Czeizel AE. 2011a. Efficacy of medical care of epileptic pregnant women based on the rate of congenital abnormalities in their offspring. Congenit Anom 51:34-42.
2. Banhidy F, Dakhlaoui A, Puho EH, Czeizel AE. 2011b. Is there a reduction of congenital abnormalities in the offspring of diabetic pregnant women after folic acid supplementation? A population-based case-control study. Congenit Anom 51:80-86.
3. Berry RJ, Li Z, Erickson JD etal. 1999. Prevention of neural-tube defects with folic acid in China. N Engl J Med 341:1485-1490.
4. Boduroglu K, Alikasifoglu M, Anar B, Tuncbilek E. 1999. Associations of the 677C→T mutation on the methylenetetrahydrofolate reductase gene in Turkish patients with neural tube defects. J Child Neurol 14:159-161.
5. Botto L, Moore CA, Khoury MJ, Erickson JD. 1999. Neural tube defects. N Engl J Med 341:1509-1519.
6. Botto LD, Lisi A, Dolk H etal. 2005. Preventing neural tube defects in Europe: a missed opportunity. Reprod Toxicol 20:393-402.
7. Christensen B, Arbour L, Tran P etal. 1999. Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am J Med Genet 84:151-157.
8. Davalos I-P, Olivares N, Castillo M-T etal. 2000. The C677T polymorphism of the methylenetetrahydrofolate reductase gene in Mexican mestizo neural-tube defect parents, control mestizo and native populations. Ann Genet 43:89-92.
9. Hamajima N, Saito T, Matsuo K, Kozaki K, Takahashi T, Tajima K. 2000. Polymerase chain reaction with confronting two-pair primers for polymorphism genotyping. Jpn J Cancer Res 91:865-868.
10. Harisha PN, Devi BI, Christopher R, Kruthika-Vinod TP. 2010. Impact of 5, 10-methylenetetrahydrofolate reductase gene polymorphism on neural tube defects. J Neurosurg Pediatrics 6:364-367.
11. Japan Association of Obstetricians and Gynecologists. 2010. Annual report of congenital malformations of 2009. Yokohama: Japan Association of Obstetricians and Gynecologists. (In Japanese.)
12. Kirke PN, Mills JL, Molloy AM etal. 2004. Impact of the MTHFR C677T polymorphism on risk of neural tube defects: case-control study. BMJ 328:1535-1536.
13. Knudsen VK, Orozova-Bekkevold I, Rasmussen LB, Mikkelsen TB, Michaelsen KF, Olsen SF. 2004. Low compliance with recommendations on folic acid use in relation to pregnancy: is there a need for fortification? Public Health Nutr 7:843-850.
14. Kondo A, Asada Y, Shibata K etal. 2011. Dietary folate intakes and effects of folic acid supplementation on folate concentrations among Japanese pregnant women. J Obstet Gynaecol Res 37:331-336.
15. Lee BH, Cheong HI, Shin Y, Cho B-K, Wang K-C. 2000. The effect of C677T mutation of methylene tetrahydrofolate reductase gene and plasma folate level on hyperhomocysteinemia in patients with meningomyelocele. Child's Nerv Syst 16:559-563.
16. Ministry of Health, Labour and Welfare, Japan. http://www1.mhlw.go.jp/houdou/1212/h1228-1_18.html (December 2012).
17. Molloy AM, Mills JL, Kirke PN etal. 1998. Low blood folates in NTD pregnancies are only partly explained by thermolabile 5.10- metylenetetrahydrofolate reductase: low folate status alone may be the critical factor. Am J Med Genet 78:155-159.
18. MRC Vitamin Study Research Group. 1991. Prevention of neural tube defects: results of the medical research council vitamin study. Lancet 338:131-137.
19. Mutchinick OM, Lopez MA, Luna L, Waxman J, Babinsky VE. 1999. High prevalence of the thermolabile metylenetetrahydrofolate reductase variant in Mexico: a country with a very high prevalence of neural tube defects. Mol Genet Metab 68:461-467.
20. Oakley GP, Jr. 2007. When will we eliminate folic acid-preventable spina bifida? Epidemiology 18:367-368.
21. Papapetrou C, Lynch SA, Burn J, Edwards YH. 1996. Methylenetetrahydrofolate reductase and neural tube defects. Lancet 348:58.
22. Perez ABA, D'Almeida V, Vergani N, de Oliveira AC, de Lima FT, Brunoni D. 2003. Metylenetetrahydrofolate reductase (MTHFR): incidence of mutations C677T and A1298C in Brazilian population and its correlation with plasma homocysteine levels in spina bifida. Am J Med Gen 119A:20-26.
23. Pietrzyk JJ, Bik-Multanowski M, Sanak M, Twardowska M. 2003. Polymorphisms of the 5, 10- methylenetetrahydrofolate and the methionine synthase reductase genes as independent risk factors for spina bifida. J Appl Genet 44:111-113.
24. Revilla JIG, Hernandez FP, Martin TC, Salvador MT, Romero JG. 2003. C677T and A1298C MTHFR polymorphisms in the etiology of neural tube defects in Spanish population. Med Clin (Barc) 120:441-445. (In Spanish.)
25. Sadewa AH, Sutomo T, Istiadjid M etal. 2004. C677T mutation in the MTHFR gene was not found in patients with frontoethmoidal encephalocele in East Java, Indonesia. Pediatr Int 46:409-414.
26. Speer MC, Worley G, Mackey JF, Melvin E, Oakes WJ, George TM, the NTD collaborative group. 1997. The thermolabile variant of methylenetetrahydrofolate reductase (MTHFR) is not a major risk factor for neural tube defect in American Caucasians. Neurogenetics 1:149-150.
27. Ubbink JB, Christianson A, Bester MJ etal. 1999. Folate status, homocysteine metabolism, and methylene tetrahydrofolate reductase genotype in rural South African blacks with a history of pregnancy complicated by neural tube defects. Metabolism 48:269-274.
28. Van der Put NMJ, Steegers-Theunissen RPM, Frosst P etal. 1995. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346:1070-1071.
29. Van der Put NMJ, Eskes TKAB, Blom HJ. 1997. Is the common 677C→T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis. Q J Med 90:111-115.
30. Wakai K, Hamajima N, Okada R etal. 2011. Profile of participants and genotype distributions of 108 polymorphisms in a cross-sectional study of associations of genotypes with lifestyle and clinical factors: a project in the Japan multi-institutional collaborative cohort (J-MICC) study. J Epidemiol 21:223-235.